We are trusted, responsive, customer-focused technical experts who provide interactive multi-channel solutions for the community pharmacy industry.
We recognize the critical business need to improve our clients’ operational efficiency in order to drive their profitability and accomplish this by providing secure and compliant cloud-based communications and analytics in a consultative and collaborative way.
VoicePort provides a suite of pharmacy service solutions that are available on an a la carte basis or bundle.
Overall Key Features:
Automated outbound interactive voice response (IVR) notifications, initiated by the pharmacy, to notify patients about prescriptions ready for pickup or due for refill or to execute an outbound patient focused program.
Other notification methods include:
Prescription reorders and other customer initiated service requests.
Medication Synchronization (MedSync) aligns numerous medications to a common refill date
A third-party integration that improves patient literacy and adherence
A third-party integration that streamlines immunization awareness
Patient Segmentation & Campaign Management
Analytics tool to group patients and execute targeted pharmacy programs.
Self service management of prescriptions and patient facing pharmacy programs.
A web-based pharmacy and patient-facing application for real-time appointment management.
A web based Pharmacy and Patient facing real time appointment management application
The cornerstone of Claro™ functionality is the ability to acquire prescription transaction data, whether from the client PMS or some other similar database or process. With the ability to integrate third party interfaces like analytic engines or performance ...Read More
Newsday partners with VoicePort for improved customer service and data analytics The rollout of VoicePort’s Contact Center is sure to disrupt the status quo for the publishing industry. In her article for the INMA’s Satisfying Audiences Blog, Jam...Read More
Time to roll up the sleeves-again. Last week the FDA, acting on the recommendation from the CDC’s Advisory Committee for Immunization Practices (ACIP), gave its approval to GSK to market Shingrix® to prevent shingles. The new guidance is based on a vaccine...Read More